Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-12-23
1995-06-27
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546206, A61K 31445, C07D21116, C07D21126
Patent
active
054280427
ABSTRACT:
##STR1## Azacyclic derivatives of formula (I), in which R.sub.1 and R.sub.2 are each linear or branched alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, cycloalkenyl or alkynyl; R.sub.3 and R.sub.4 are identical, and each is a hydrogen or alkyl; and R.sub.5 is hydrogen or alkyl, and their use in medicine are disclosed.
REFERENCES:
patent: 4753952 (1988-06-01), Vecchietti
patent: 4806547 (1989-02-01), Giardina
patent: 4826819 (1989-05-01), Vecchietti
patent: 4999359 (1991-03-01), Vecchietti
patent: 5030649 (1991-07-01), Vecchietti
patent: 5041451 (1991-08-01), Colle
patent: 5087630 (1992-02-01), Colle
patent: 5089507 (1992-02-01), Vecchietti
patent: 5254564 (1993-10-01), Vecchietti
Engel et al., J. Med. Chem., 32(8), 1718-1724 1989.
Brooks et al., Opiate Receptors within the Blood-Brain Barrier Mediate Kappa Agonist-Induced Water Diuresis, J. Pharmacol. Exp. Ther., 266, 164 (1993).
Silvia et al., Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist, Brain Res., 403, 52 (1987).
Hall et al., Stroke, Quantitative Analysis of Effects of .kappa.-Opioid Agonists on Postischemic Hippocampal CA1 Neuronal Necrosis in Gerbils, 19, 8 1008 (1988).
Journal of Medicinal Chemistry, vol. 32, No. 8, Aug. 1989, American Chemical Society, (Washington, D.C., US) W. W. Engel et al: "Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M.sub.2) anti-muscarinics", pp. 1718-1724.
Colle Roberto
Giardina Giuseppe
Vecchietti Vittorio
Dr Lo Zambeletti S.p.A.
Henley III Raymond
Kinzig Charles M.
Lentz Edward T.
Spivack Phyllis G.
LandOfFree
1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-287774